Europe Non-Invasive Aesthetic Treatment Market

Market Introduction

Non-invasive or non-surgical aesthetic treatment refers to the aesthetic procedures that does not require any kind of surgical incision. Sometimes, minimally invasive surgeries are also considered as non-surgical procedures. Some of the commonly conducted non-invasive aesthetic treatment includes botulinum toxin injection, chemical peels, non-surgical laser treatment, and microdermabrasion amongst other.

Europe Non-Invasive Aesthetic Treatment Strategic Insights

Strategic insights for the Europe Non-Invasive Aesthetic Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Non-Invasive Aesthetic Treatment Report Scope

Europe Non-Invasive Aesthetic Treatment Regional Insights

The geographic scope of the Europe Non-Invasive Aesthetic Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Europe non-invasive aesthetic treatment market is expected to reach US$ 5,830.17 million by 2028 from US$ 2,337.83 million in 2021, it is estimated to grow at a CAGR of 13.9% from 2021 to 2028. The growth of the market is attributed to a few key driving factors such as surging awareness about cosmetic procedures among consumers and availability of technologically advanced products. However, clinical risks and complications associated with medical aesthetic procedures are hindering the market growth.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their noninvasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Moreover, non-invasive treatments are gaining traction due to high preference for less downtime post treatment. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people. For example, the government in England began a campaign in 2019 on botched cosmetic procedures and their influence on a person’s physical and mental health. Therefore, the growing awareness regarding non-invasive aesthetic treatment procedures is boosting the growth of the Europe non-invasive aesthetic treatment market. Several manufacturers are working on advanced non-invasive aesthetic treatment products. Therefore, the availability of user-friendly, technologically advanced non-invasive aesthetic treatment products is fuelling the market growth.

The COVID-19 pandemic has slightly hindered the medical device industry in Europe. Various companies have shut down their productions; hence, they are unable to meet the rising demand. The routine health care services have remained suspended. On the other hand, the number of COVID-19 confirmed cases has grown significantly, and it has raised the question regarding safety from the aesthetic treatments done by lasers and micro-needling. Thus, aesthetic services have been shut down in European countries. Hence, it is expected that the negative impact on the Europe non-invasive aesthetic treatment market will continue in the following a few years.

Key Market Segments

The Europe non-invasive aesthetic treatment market, based on procedure, is segmented into injectables, skin rejuvenation, and others. The injectables segment held the largest share of the market in 2020, and the market for the same segment is expected to grow at the fastest rate during the forecast period.

The Europe non-invasive aesthetic treatment market, by end user, is segmented into hospitals, clinics and medical spas, and others. The hospitals segment held the largest share of the market in 2020. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Europe non-invasive aesthetic treatment market are the British Association of Aesthetic Plastic Surgeons (BAAPS), German Association for Aesthetic & Plastic Surgery (DGAPC), and Socio-Economic Contribution of the European Cosmetics Industry (SECECI).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Europe non-invasive aesthetic treatment market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Europe non-invasive aesthetic treatment market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe non-invasive aesthetic treatment market.

EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET SEGMENTATION

By Procedure

• Injectables
  • Botulinum Toxin
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Polymer Filler
  • Collagen
• Skin Rejuvenation
  • Chemical Peel
  • Laser Skin Resurfacing
  • Photorejuvenation
• Others
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Sclerotherapy
  • Cellulite Treatment

By

End User

• Hospitals
• Clinics and Medical Spas
• Others

By Country

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Company Profiles

• Galderma
• Alma Lasers
• Merz Pharma
• Bausch Health Companies Inc.
• Cutera Inc.
• AbbVie Inc.
• Candela Medical
• Johnson and Johnson Services, Inc.